DNA Earnings

DNA reported its earnings on 2026-03-09, showcasing a revenue of against an estimate of 37.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -1.8 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following DNA's earnings announcement on 2026-03-09, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, DNA's stock price tends to shift by an average of 10.21% in the 10 days leading up to earnings and -13.79% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate DNA's annual revenue to reach 37.69M, while the EPS is projected at -1.80. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between DNA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, DNA's stock price typically moves by 10.21% in the 10 days before its earnings and -13.79% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -1.80 and revenue of 37.69M.

The earnings call reveals improvements in financial metrics, including reduced operating losses and cash burn due to restructuring. Although revenue decreased, optimistic guidance and strategic initiatives in AI and robotics present potential growth avenues. The Q&A section highlights positive reception of new services and potential revenue tailwinds. However, management's vague response on U.S. onshoring introduces some uncertainty. Overall, the positive elements, such as improved financial health and strategic growth plans, outweigh negatives, suggesting a likely positive stock price movement.